Recent advances in angiotensin II signaling

Brazilian Journal of Medical and Biological Research

Volumn 35, Issue 9, 2002, Pages 1001-1015

  Touyz, R M ^a   Berry, C ^b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Angiotensin receptors; Phospholipase; Protein kinase; Reactive oxygen species; Second messengers

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CALCIUM ION; EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; HORMONE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE C; PROTEIN P130; PROTEIN TYROSINE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SOMATOMEDIN RECEPTOR; STAT PROTEIN;

ANIMAL CELL; APOPTOSIS; ATHEROSCLEROSIS; CALCIUM MOBILIZATION; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL GROWTH; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HYPERTENSION; INFLAMMATION; NATRIURESIS; NONHUMAN; PATHOGENESIS; PROTEIN INTERACTION; RAT; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SODIUM RETENTION; TRANSACTIVATION; VASOCONSTRICTION; VASODILATATION; WATER RETENTION;

ANIMALIA; JANUS;

EID: 0036762815     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2002000900001     Document Type: Review

References (60)

1. Matsusaka T & Ichikawa I (1997). Biological functions of angiotensin and its receptors. Annual Review of Physiology, 59: 395-412.
2. Kim S & Iwao H (2000). Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacological Reviews, 52: 11-34.
3. Ardaillou R (1999). Angiotensin II receptors. Journal of the American Society of Nephrology, 10: S30-S39.
4. de Gasparo M, Husain A, Alexander W, Catt KJ, Chiu AT, Drew M, Goodfriend T, Harding JW, Inagami T & Timmermans BMWM (1995). Proposed update of angiotensin receptor nomenclature. Hypertension, 25: 924-927.
5. Swanson GN, Hanesworth JM, Sardinia MF, Coleman JK, Wright JW, Hall KI, Miller-Wing AV, Cook VI, Harding ECE & Harding JW (1992). Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regulatory Peptides, 40: 409-419.
6. deGasparo M & Levens N (1998). Does blockade of angiotensin II receptors offer clinical benefits over inhibition of angiotensin-converting enzyme? Pharmacology and Toxicology, 82: 257-271.
7. 1 receptors. American Journal of Hypertension, 13: 31S-38S.
8. Berk BC & Corson MA (1997). Angiotensin II signal transduction in vascular smooth muscle. Role of tyrosine kinases. Circulation Research, 80: 607-616.
9. Nahmias C & Strosberg D (1995). The angiotensin AT receptor: searching for signal-transduction pathways and physiological function. Trends in Pharmacological Sciences, 16: 223-225.
10. Horiuchi M, Hayashida W, Kambe T, Yamada T & Dzau VJ (1997). Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. Journal of Biological Chemistry, 272: 19022-19026.
11. 2 receptors in angiotensin II-stimulated contraction of small arteries in young SHR. Hypertension, 33 (Part 2): 366-373.
12. Phoon S & Howes LG (2001). Role of angiotensin type 2 receptors in human forearm vascular responses of normal volunteers. Clinical and Experimental Pharmacology and Physiology, 28: 734-736.
13. Ichihara S, Senbonmatsu T, Price E, Ichiki T, Gaffney A & Inagami T (2001). Ang II type 2 receptor is essential for left ventricular hypertrophy fibrosis in chronic Ang II-induced hypertension. Circulation, 104: 346-351.
14. Horiuchi M, Akishiita M & Dzau VJ (1999). Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension, 33: 613-621.
15. Alexander RW, Brock TA, Gimbrone Jr MA & Rittenhouse SE (1985). Angiotensin increases inositol trisphosphate and calcium in vascular smooth muscle. Hypertension, 7: 447-451.
16. Ushio-Fukai M, Griendling KK, Akers M, Lyons PR & Alexander RW (1998). Temporal dispersion of activation of phospholipase C-beta 1 and -gamma isoforms by angiotensin II in vascular smooth muscle cells. Role of alphaq/11, alpha12, and beta gamma G protein subunits. Journal of Biological Chemistry, 273: 19772-19777.
17. Touyz RM & Schiffrin EL (1997). Role of calcium influx and intracellular calcium stores in angiotensin II-mediated calcium hyperresponsiveness in smooth muscle from spontaneously hypertensive rats. Journal of Hypertension, 15: 1431-1439.
18. Billah MM (1993). Phospholipase D and cell signaling. Current Opinion in Immunology, 5: 114-123.
19. Ushio-Fukai M, Alexander RW, Akers M, Lyons PR, Lassègue B & Griendling KK (1999). Angiotensin II receptor coupling to phospholipase D is mediated by the βγ subunits of heterotrimeric G proteins in vascular smooth muscle cells. Molecular Pharmacology, 55: 142-149.
20. Dhalla NS, Xu Y-J, Sheu S-S, Tappia PS & Panagia V (1997). Phosphatidic acid: a potential signal transducer for cardiac hypertrophy. Journal of Molecular and Cellular Cardiology, 29: 2865-2871.
21. Touyz RM & Schiffrin EL (1999). Ang II-stimulated generation of reactive oxygen species in human vascular smooth muscle cells is mediated via PLD-dependent pathways. Hypertension, 34 (Part 2): 976-982.
22. 2 and signal transduction. Journal of the American Society of Nephrology, 3: 128-150.
23. Nasjletti A (1997). The role of eicosanoids in angiotensin-dependent hypertension. Hypertension, 31 (Part 2): 194-200.
24. Oyekan A, Balazy M & McGiff JC (1997). Renal oxygenases: differential contribution to vasoconstriction induced by endothelin-1 and angiotensin II. American Journal of Physiology, 273 (Part 2): R293-R300.
25. Thomas SM & Brugge JS (1997). Cellular functions regulated by Src family kinases. Annual Review of Cell Division, 13: 513-609.
26. Erpel T & Courtneidge SA (1995). Src family protein tyrosine kinases and cellular signal transduction pathways. Current Opinion in Cell Biology, 7: 176-182.
27. 2+ signaling by angiotensin II in human vascular smooth muscle cells. Journal of Hypertension, 19: 441-449.
28. 2+, and protein kinase C. Circulation Research, 82: 1279-1288.
29. Ihle JN (1995). Çytokine receptor signalling. Nature, 377: 591-594.
30. Marrero MB, Schieffer B, Li B, Sun J, Harp JB & Ling BN (1997). Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. Journal of Biological Chemistry, 272: 24684-24690.
31. Leduc I & Meloche S (1995). Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion protein paxillin in aortic smooth muscle cells. Journal of Biological Chemistry, 270: 4401-4404.
32. Guan JL (1997). Role of focal adhesion kinase in integrin signaling. International Journal of Biochemistry and Cell Biology, 29: 1085-1096.
33. Tang H, Zhao ZJ, Landon EJ & Inagami T (2000). Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of yes tyrosine kinase and tyrosine phosphatase shp-2. Journal of Biological Chemistry, 275: 8389-8396.
34. Cary LA, Han DC, Polte TR, Hanks SK & Guan JL (1998). Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration. Journal of Cell Biology, 140: 211-221.
35. Cas and c-Crk II by Ang II in vascular smooth muscle cells. American Journal of Physiology, 274 (Part 2): H1059-HI065.
36. Leevers SJ, Vanhaesebroek B & Waterfield MD (1999). Signaling through phosphoinositide 3-kinases: the lipids take centre stage. Current Opinion in Cell Biology, 11: 219-225.
37. Saward L & Zahradka P (1997). Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circulation Research, 81: 249-257.
38. Takahashi T, Taniguchi T, Konishi H, Kikkawa U, Ishikawa Y & Yokoyama M (1999). Activation of Akt/PKB after stimulation with Ang II in vascular smooth muscle cells. American Journal of Physiology, 276 (Part 2): H1927-H1934.
39. Saito Y & Berk BC (2001). Transactivation: a novel signaling pathway from Ang II to tyrosine kinase receptors. Journal of Molecular and Cellular Cardiology, 33: 3-7.
40. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C & Ullrich A (1999). EGF receptor transactivation by G protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature, 402: 884-888.
41. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KIM, Hirata Y, Marumo F & Inagami T (1998). Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells, Journal of Biological Chemistry, 273: 8890-8896.
42. Robinson MJ & Cobb MH (1997). Mitogen-activated protein kinase pathways. Current Opinion in Cell Biology, 9: 180-186.
43. Touyz RM, He G, Deng LY & Schiffrin EL (1999). Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance vessels. Circulation, 99: 392-399.
44. Touyz RM, He G, El Mabrouk M, Diep Q, Mardigyan V & Schiffrin EL (2001). Differential activation of ERK1/2 and p38MAP kinase by angiolensin II type I receptor in vascular smooth muscle cells from WKY and SHR. Journal of Hypertension, 19: 553-559.
45. Ip YT & Davis RJ (1998). Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Current Opinion in Cell Biology, 10: 205-219.
46. Schmitz U, Ishica T, Ishida M, Surapisitchat J, Hasham MI, Pelech S & Berk BC (1998). Angiotensin II stimulates p2l-activated kinase in vascular smooth muscle cells. Role in activation of JNK. Circulation Research, 82: 1272-1278.
47. Liao DF, Monia B, Dean N & Berk BC (1997). Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. Journal of Biological Chemistry, 272: 6146-6150.
48. Ushio-Fukai M, Alexander RW, Akers M & Griendling KK (1998). p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. Journal of Biological Chemistry, 273: 15022-15029.
49. Duff JL, Monia BP & Berk BC (1995). Mitogen-activated protein kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Journal of Biological Chemistry, 270: 7161-7166.
50. Laufs U & Liao JK (2000). Targeting Rho in cardiovascular disease. Circulation Research, 87: 526-528.
51. Somlyo AP & Somlyo AV (2000). Signal transduction by G protein, Rho kinase and protein phosphatase to smooth muscle and non-muscle myosin II. Journal of Physiology, 522: 177-185.
52. Yamakawa T, Tanaka S-I, Numaguchi K, Yamakawa Y, Motley ED, Ichihara S & Inagami T (2000). Involvement of Rho kinase in Ang II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension, 35: 313-318.
53. Funakoshi Y, Ichiki T, Shimokawa H, Egashira K, Takeda K, Kaibuchi K, Takeya M, Yoshimura T & Takeshita A (2001). Rho kinase mediates Ang II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Hypertension, 38: 100-104.
54. Griendling KK & Ushio-Fukai M (1997). NADH/NADPH oxidase and vascular function. Trends in Cardiovascular Medicine, 7: 310-317.
55. Rueckschloss U, Galle J, Holtz J, Zerkowski H & Morawietz H (2001). Induction of NAD(P)H oxicase by oxidised low-density lipoprotein in human endothelial cells. Antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation, 104: 1767-1772.
56. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg G, McMurray JJV & Dominiczak AF (2000). An investigation into the sources of superoxide production in human blood vessels: Angiotensin II increases superoxide production in human internal mammary arteries. Circulation, 101: 2206-2212.
57. Laursen JB, Rajagopalan S, Galis Z, Tarpet M, Freeman BA & Harrison DG (1997). Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation, 95: 588-593.
58. Hsueh WA, Do YS, Anderson PW & Law RE (1995). Angiotensin II in cell growth and matrix production. Advances in Experimental Medicine and Biology, 377: 217-223.
59. Berry C, Touyz RM, Dominiczak AF, Webb RC & Johns DG (2001). Angiotensin receptors: Signaling, vascular pathophysiology and interactions with ceramide. American Journal of Physiology, 281: H2337-H2365.
60. Touyz RM & Schiffrin EL (2000). Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacological Reviews, 52: 639-672.